Results 151 to 160 of about 13,510,761 (277)

Shadowed Fading in Indoor Off-Body Communication Channels: A Statistical Characterization Using the $\kappa $ –$\mu $ /Gamma Composite Fading Model

, 2016
Seong Ki Yoo, Simon L. Cotton, Paschalis C. Sofotasios, Steven Freear   +3 more
openalex   +1 more source

The HCUP SID Imputation Project: Improving Statistical Inferences for Health Disparities Research by Imputing Missing Race Data [PDF]

, 2017
Yan Ma, Wei Emma Zhang, Stephen Lyman, Yihe Huang   +3 more
openalex   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

Molecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto, Louise Raunkilde, Jan Lindebjerg, Mads Malik Aagaard, Christina Therkildsen, Jakob Kleif, Lars Henrik Jensen, Torben Frøstrup Hansen, Rikke Fredslund Andersen   +8 more
wiley   +1 more source

In situ tuning and investigating the growth process of size controllable gold nanoparticles and statistical size prediction analysis

, 2023
Vinayak Sharma, Bilal Javed, Giovani Estrada, Hugh J. Byrne, Furong Tian   +4 more
openalex   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Molecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice, Jose I. Lopez, Aitziber Ugalde‐Olano, Maite Zufiaurre, Ianire Astobiza, Natalia Martin‐Martin, Laura Bozal‐Basterra, Saioa Garcia‐Longarte, Amaia Zabala‐Letona, Sofia Rey, Aida Santos‐Martin, Miguel Unda, Ana Loizaga‐Iriarte, Mariona Graupera, Paolo Nuciforo, Arkaitz Carracedo, Isabel Mendizabal   +16 more
wiley   +1 more source

Influence of soil properties on crop yield: a multivariate statistical approach

, 2015
Katalin Juhos, Szilárd Szabó, Márta Ladányi   +2 more
openalex   +1 more source

Statistical Analysis for Tidal Flat Classification and Topography Using Multitemporal SAR Backscattering Coefficients [PDF]

, 2021
Keunyong Kim, Hahn Chul Jung, Jong-Kuk Choi, Joo‐Hyung Ryu   +3 more
openalex   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Effect of Quality Control Circle Activities on Reducing the Failure Rate of Surgical Instrument Pre-Treatment

Risk Management and Healthcare Policy
Yandan Wang,1 Xiulan Zhou,2 Yanqiu Zhu,1 Yuanmei Dan,1 Zeping Huang,1 Ling Xiang1 1Department of Sterile Processing Nursing, Sichuan Friendship Hospital, Chengdu, Sichuan, People’s Republic of China; 2Department of Nursing, Sichuan Friendship Hospital ...
Wang Y, Zhou X, Zhu Y, Dan Y, Huang Z, Xiang L   +5 more
doaj  

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source